Portfolio company
Haermonics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops automated pericardial flushing systems to prevent blood clots and drainage complications for patients recovering from open-heart surgery.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
preCARDIA
This company develops catheter-based systems for heart failure specialists to treat patients suffering from acute decompensated heart failure and volume overload.
CoreMedic
This company develops transcatheter heart valve repair systems to treat mitral valve regurgitation for patients requiring minimally invasive cardiac interventions.
Reprieve Cardiovascular
This company develops automated fluid management systems to manage decongestion in patients with acute decompensated heart failure.
Claret Medical
This company develops cerebral embolic protection systems that capture and remove debris during cardiovascular procedures for hospitals and heart surgeons.
Miracor Medical SA
This company develops a pressure-controlled intermittent coronary sinus occlusion system to treat patients with impaired cardiac function and heart attacks.
CardioMech
CardioMech develops a transcatheter-based artificial chordae delivery system for hospitals to treat patients suffering from degenerative mitral regurgitation without open-heart surgery.
CardiacBooster
This medical device company develops percutaneous ventricular assist devices for patients suffering from cardiogenic shock or undergoing high-risk coronary procedures.
Sealonix
This company develops bioabsorbable hemostatic sealant patches to control surgical bleeding for healthcare providers performing abdominopelvic and orthopaedic procedures.
